June 10, 2019
Merck to Acquire Tilos Therapeutics
Merck Gains Portfolio of Investigational Antibodies Modulating TGFβ KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United…
Pharmaceuticals, Biotechnology and Life Sciences
Merck Gains Portfolio of Investigational Antibodies Modulating TGFβ KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United…
DUBLIN–(BUSINESS WIRE)–The “Global Hospital Care Partnering 2014-2019: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. Global…
DUBLIN–(BUSINESS WIRE)–The “Global Hematology Partnering 2014-2019: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. Global Hematology…
DUBLIN–(BUSINESS WIRE)–The “Global Immunology Partnering 2014-2019: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. Global Immunology…
LEHI, Utah–(BUSINESS WIRE)–Frelii Inc. (OTC PINK: FRLI) (“Frelii” or “the Company”) today announced the details of its recent agreement with…
DUBLIN–(BUSINESS WIRE)–The “Leukemia Therapeutics Market by Type (CLL, ALL, CML, AML), Treatment Type (Chemotherapy & Targeted Drugs), Mode of Administration…
DUBLIN–(BUSINESS WIRE)–The “Global Microbiome Partnering Terms and Agreements 2014 to 2019” report has been added to ResearchAndMarkets.com’s offering. The Global…
Results from DARZALEX® ▼ (daratumumab) Phase 3 CASSIOPEIA study in newly diagnosed transplant eligible patients with multiple myeloma selected for…
HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as…
Multi-year research collaboration and software agreement reimagines the discovery and clinical development of medicines through data sciences CAMBRIDGE, Mass.–(BUSINESS WIRE)–nference,…